RLYB-114

N/A

Report date: 2025/05/14 15:50:03

Base Information

Drug NameRLYB-114
Drug Alias NameRLYB-114
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionComplement C5 inhibitors
TargetsComplement C5
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRallybio Llc
China Registration ClassN/A

Develop Information

Active CompaniesRallybio Llc
Inactive CompaniesN/A
Active IndicationsEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A